After setbacks, Sanofi/GlaxoSmithKline COVID vaccine performs well in early trial
Newly discovered epigenetic regulatory mechanisms involved in multiple myeloma growth
17 May 2021Prenatal detection of heart defects lower in rural, poor areas and among Hispanic women
17 May 2021After setbacks, Sanofi/GlaxoSmithKline COVID vaccine performs well in early trial
Sanofi and GlaxoSmithKline announced Monday that their coronavirus vaccine candidate produced powerful responses in a preliminary trial that followed an earlier setback in the vaccine’s development.
